v3 Template
T

Theromics Inc.

Biotechnology / Medical Device Technology ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$1.0M
Funding Rounds
1
Last Funding
2024-03-12

About Theromics Inc.

Theromics Inc. is a biotechnology company focused on developing next-generation thermal accelerant technology to enhance soft tissue ablation procedures and enable more precise and effective drug delivery. Founded in 2016 as a spin-out from Brown University, the company aims to optimize treatment strategies for various medical indications using proprietary nanogels.

Products & Services

HeatSYNC™ Gel:A biocompatible, protein-based nanogel that enhances energy transfer in tissue, improving thermal ablation procedures by creating larger, more spherical ablation zones in less time. It also supports targeted drug delivery and is applicable in soft tissue ablations, women's health (e.g., uterine fibroids), and other minimally invasive treatments.
CryoSYNC Gel:A biocompatible nanogel designed to enhance cryoablation performance, facilitating energy transfer in tissue for more effective soft tissue ablations. It is compatible with various ablation modalities.
TACT - Thermally Activated Combination Therapy:An innovative therapy combining ablation with targeted drug delivery using Theromics' nanogels to localize treatment and reduce systemic side effects of traditional therapies.

Specialties

Thermal Accelerant Technology Soft Tissue Ablation Drug Delivery Minimally Invasive Treatments Women's Health (Uterine Fibroids) Nanopolymer Platform Technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: STTR Phase II Grant
T: -
FT: STTR Phase II Grant 		A: 1000000
MR: -
FA: $1M
FAN: 1000000 		D: 2024-03-12
FD: 2024-03-12 		1 investors
STTR Phase II Grant Latest
2024-03-12
$1.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Suman Lal

Chief Executive Officer

LinkedIn (Pro only)
W

William K.C. Park

Co-Founder & Chief Scientific Officer

LinkedIn (Pro only)
D

Damian Dupuy

Co-Founder & Chief Medical Officer

LinkedIn (Pro only)

Recent News

Theromics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Medical Device Technology
Company Size
~30 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro